Exploring the Efficacy Evaluation Model for Androgenic Alopecia Using Hair Organoids: Transcending Conventional Hair Research

This study introduces a novel hair-bearing organoid model derived from embryonic stem cells to evaluate treatments for androgenic alopecia (AGA). The organoids effectively mimic scalp and hair follicle characteristics and were used to model AGA by treating them with dihydrotestosterone (DHT). The research validated the efficacy of minoxidil (MXD) and soybean embryo extract (SOYACT) in promoting hair growth and restoring biomarkers reduced by DHT. The findings suggest that hair organoids provide a robust platform for preclinical testing of anti-hair loss therapies, offering a promising alternative to traditional in vitro systems and animal testing. Despite some limitations, such as replicating the full complexity of human hair and scalp functions, the study highlights the potential of organoids as versatile tools bridging in vitro and clinical studies.